OpenCapital
Beta
Calendar
Stocks
Metrics
Connect AI
/
Stocks
Portfolio
Sign In
Toggle navigation menu
Stocks
KLR
Kailera Therapeutics
Cash Flow Statement
Change in other non-current liabilities
Operating
Change in other non-current liabilities
Export Chart
Analysis
Statement
Cash Flow Statement
Section
Operating
First reported
Q1 2025
Last reported
Q1 2026
May 26, 2026
Metric ID:
mu_change_in_other_noncurrent_liabilities
Historical Data
2 periods
Quarterly
Q1 '25
Q1 '26
Value
$0.00
-$69.00K
Range
-$69.00K – $0.00
Frequently Asked Questions
What is Kailera Therapeutics 's change in other non-current liabilities?
Kailera Therapeutics (KLRA) reported change in other non-current liabilities of -$69.00K in Q1 2026.